Wasim Gul

Clinical Pharmacist - all views are my own.

[Wasim Gul @Was_Gul]

@UKPHOENIXpeople Birmingham depot is an operational shambles. Nearly lost 1k in pharma, had photo evidence deliveries had failed.

[Wasim Gul @Was_Gul]

@curryspcworld returned a faulty labtop 7 days ago. Still heard nothing back - phoned and got told it's not even been booked in yet. Asked for a turnaround, answer = unknown
= shambles

[Wasim Gul @Was_Gul]

@DudleyGroupNHS @dav_manku @BCLivingMuseum @DudleyCCG @HealthierBCWB Well done Dav!

[Wasim Gul @Was_Gul]

@saleem_nur @RxWebTeam @ChemistDruggist

[Wasim Gul @Was_Gul]

@RxWebTeam shambolic update , core pharmacy services now down for 3 hours. Mickey mouse company

[Wasim Gul @Was_Gul]

@DudleyGroupNHS @FabNHSStuff Congratulations! Such an awesome idea!

[The Dudley Group @DudleyGroupNHS]

Pharmacists Sarah Baig and Leanne Nation got a big thumbs up from our 'Director Dragons'! 👍👍👍 #FabChangeWeek @FabNHSStuff

[Oncology Times @OncologyTimes]

Immune Checkpoint Inhibitors & the Defense of the Immune System https://t.co/oGLLFQCaTN via @UTSWNews #cancertreatment #healthcare

[The Dudley Group @DudleyGroupNHS]

Pharmacists Graeme Hood and Dav Manku informing people about chemotherapy treatment and how it's prepared in our aseptic unit
#AMM2017

[Wasim Gul @Was_Gul]

@DudleyMedicines Could GP's and pain teams restrict usage and initiation?

[Wasim Gul @Was_Gul]

@DudleyMedicines Interesting, is more regulation the solution? we might aswell start increasing regulation on all neuropathic agents on this line of thought

[Oncology Times @OncologyTimes]

Identifying Relapse-Causing #BreastCancer Cells https://t.co/BJjI8UfMH1 via @embl #bcsm #cancer

[ASCO @ASCO]

Targeting B-Cell Receptor Signaling for Anticancer Therapy: Understanding the Pathway https://t.co/eFnTnuLtXH

[ASCO @ASCO]

The Role of Front-Line Bendamustine Plus Rituximab in Indolent NHL and MCL: https://t.co/ABvBKQHPIn #ASCO17

[Yousuf Zafar, MD MHS @yzafar]

Wow.

#ASCO17

[Wasim Gul @Was_Gul]

@SarimYousafzai Welcome back

[UCL Innovative Clinical Trials Unit @innovativectu]

STAMPEDE finds that adding abiraterone to standard hormone therapy improves prostate cancer survival #ASCO17

[ASCO @ASCO]

Challenges of Treating Elderly Patients With Myeloma: https://t.co/5duMPeS8o8 #ASCO17

[Oncology Times @OncologyTimes]

Approved Use of Regorafinib Expanded to Treat #LiverCancer @US_FDA https://t.co/9NCstS2xv0

[Hadar Zaman @hadar_zaman1]

SGLT2 inhibitors: updated advice on increased risk of lower-limb amputation (mainly toes) Drug Safety Update - https://t.co/8Z8VWLvK1o